Skip to main content
VIYASH SCIENTIFIC LIMITED logo

VIYASH SCIENTIFIC LIMITED — Investor Relations & Filings

Ticker · VIYASH ISIN · INE807F01027 LEI · 335800SXM7D3VSHF2X07 BSE.NS Manufacturing
Open in API
Filings indexed 1,420 across all filing types
Latest filing 2026-02-10 Proxy Solicitation & In…
Country IN India
Listing BSE.NS VIYASH

About VIYASH SCIENTIFIC LIMITED

https://www.viyash.com

Viyash Scientific Limited is an integrated pharmaceutical platform specializing in the development and manufacturing of Active Pharmaceutical Ingredients (APIs), advanced intermediates, and finished dosage forms. The organization operates a network of manufacturing facilities supported by robust research and development capabilities, focusing on complex chemistry and niche therapeutic segments. Its core business activities encompass the entire pharmaceutical value chain, from process development and scale-up to commercial-scale production. The company provides integrated solutions to global partners, leveraging its technical expertise in chemical synthesis and commitment to international quality standards. By maintaining a focus on operational excellence and innovation, the company serves as a strategic partner in the global healthcare supply chain, delivering high-quality medicinal components and formulations.

Recent filings

Filing Released Lang Actions
Shareholders meeting
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Postal Ballot Notice from Viyash Scientific Limited, dated February 10, 2026. It includes detailed information about proposed resolutions to be approved by shareholders via remote e-voting, including appointments and remuneration of directors and grant of stock options. The document references compliance with SEBI Listing Regulations and Companies Act provisions, and it outlines the voting schedule and procedures. It is not a report of voting results, nor a full annual or interim financial report, nor a management discussion or earnings release. It is a formal notice to shareholders seeking their approval on specific corporate governance matters. Therefore, this document fits the category of Proxy Solicitation & Information Statement (PSI), as it is material sent to shareholders to provide information and request votes for meetings or resolutions.
2026-02-10 English
Postal ballot Notice
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Postal Ballot Notice from Viyash Scientific Limited dated February 10, 2026. It details the agenda for shareholder voting via remote e-voting, including appointments and remuneration of directors and grant of stock options. It references compliance with SEBI Listing Regulations and Companies Act provisions. The document is a notice to shareholders to vote on specific resolutions and includes procedural details about the e-voting process and timelines. It does not contain financial statements, audit results, earnings data, or management discussion and analysis. It is not a report but a formal announcement seeking shareholder approval on governance matters. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it relates to the voting process and resolutions to be approved by shareholders. However, since this document is the notice for the postal ballot and not the actual voting results, it is more precisely a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings. Given the detailed agenda and explanatory statements, the best classification is PSI.
2026-02-10 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a detailed transcript of an earnings conference call held by Viyash Scientific Limited for the quarter and nine months ended December 31, 2025. It includes management commentary on financial results, business performance, strategic initiatives, and outlook. The text explicitly mentions it is an "Earnings Conference Call" and contains a Q&A format typical of call transcripts. It references quarterly financial results and discusses operational and financial highlights in detail. There is no indication that this is a brief earnings release or a summary; rather, it is a full transcript of the call. Therefore, the document fits the category of a Call Transcript (CT).
2026-02-09 English
Earning call Transcript for the quarter and nine month ended December 31, 2025
Call Transcript Classification · 100% confidence The document is a detailed transcript of an earnings conference call held by Viyash Scientific Limited for the quarter and nine months ended December 31, 2025. It includes management commentary on financial results, business performance, strategic initiatives, and outlook. The text explicitly mentions it is an "Earnings Conference Call" and contains a full transcript of the call with management remarks and Q&A format. It is not a brief announcement or a summary but a full transcript of the call. Therefore, the document fits the definition of a Call Transcript (CT).
2026-02-09 English
Newspaper Publication -Financial Result for Q3 FY 26
Interim / Quarterly Report Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding the publication of extracts of unaudited financial results for the quarter and nine months ended December 31, 2025. It references Regulation 30 & 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs disclosure of financial results. The document includes a newspaper advertisement copy containing extracts of unaudited standalone and consolidated financial results, along with a QR code to access full financial results. The document is 6178 characters long, which is sufficient to contain substantive financial data. The content is focused on quarterly and nine-month financial results, which are interim periods shorter than a full fiscal year. Therefore, this document is a comprehensive interim/quarterly financial report containing actual financial data and analysis, not merely an announcement or certification. Hence, the appropriate classification is Interim / Quarterly Report (IR). 9M 2026
2026-02-07 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding the publication of extracts of unaudited financial results for the quarter and nine months ended December 31, 2025. It references Regulation 30 & 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs disclosure of financial results. The document includes a newspaper advertisement copy containing extracts of unaudited standalone and consolidated financial results, along with a QR code to access full financial results. The document length is 6178 characters, which is relatively short and primarily serves as an announcement of the financial results publication rather than the full financial report itself. There is no detailed financial data or comprehensive financial statements included in the text. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement of financial results publication and not the full Interim/Quarterly Report (IR) or Annual Report (10-K).
2026-02-07 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.